03/12/2020 - General information
The Catalonian Antidoping Laboratory first obtained the ISO17025 accreditation 20 years ago, in November 2000. The laboratory has been accredited as an anti-doping laboratory since 1985 and is one of 30 laboratories in the world accredited by the World Anti-Doping Agency (WADA). The ISO17025 accreditation of all analytical procedures applied in doping controls was a prerequisite for maintaining doping accreditation from 2001 onwards. ISO17025 is an internationally recognised quality standard designed to guarantee the technical competence of testing laboratories, in other words, to ensure that laboratories deliver accurate, reliable results. In Spain, ISO17025 accreditation is awarded by ENAC (Entidad Nacional de Acreditación), a Spanish Government body.
Més informació "The Catalonian Antidoping Laboratory celebrates 20 years of ISO17025 accreditation."
2/12/2020 - Press release
The article published in the journal World Psychiatry and endorsed by the informal scientific network of the United Nations Office on Drugs and Crime (UNODC) and the World Health Organisation (WHO), and including the United States National Institute of Drug Abuse (NIDA), validates and corroborates the approach to the dual diagnosis implemented at Hospital del Mar for patients being treated for addiction to a substance of abuse who, in addition, suffer another psychiatric pathology. Dual diagnosis is a major health problem that causes, according to the article, an increased number of emergencies in healthcare centres, as well as more psychiatric hospitalisations, a higher risk of relapse into drug use and premature death, including suicide. This has individual and social repercussions, as well as consequences for healthcare systems, and means that a multidisciplinary and comprehensive approach is required. Nevertheless, as the authors of the paper point out, there is a generalised lack of preparedness to deal with this situation.
01/12/2020 - Press release
The public-private consortium formed by the biotech company Connecta Therapeutics, the Centre for Genomic Regulation (CRG) and the Hospital del Mar Medical Research Institute (IMIM) has received a grant for 1,970,520 Euro from the Spanish National Innovation Agency to develop an innovative treatment for fragile X syndrome (FXS), the most common form of hereditary intellectual disability. The grant comes from the 2019 "Collaboration Challenges" call for projects of the National R&D&I Programme geared towards societal challenges. The call received 420 applications, 158 of which will be funded.
30/11/2020 - General information
Dr. Dr. María Martínez, head of the neuro-oncology section of the Medical Oncology Service at Hospital del Mar and a researcher in the Cancer Molecular Therapy research group at the Hospital del Mar Medical Research Institute, will chair the Spanish Neuro-Oncology Research Group (Grupo Español de Investigación en Neurooncología; GEINO) for the next two years. Her appointment was confirmed on 27th November at the organisation's assembly, which was held virtually. Dr. Martínez explained that her objective at the head of GEINO is "To maintain and strengthen the execution of clinical trials in neuro-oncology, both for primary central nervous system tumours and brain metastases, and to continue down the same path as the previous chairmanship with regard to the most basic and translational researchers, as well as to build bridges and collaborate with other cooperative groups".
Més informació "Dr. María Martínez, new president of the Spanish Neuro-Oncology Research Group"
27/11/2020 - General information
Research involving doctors and researchers from Hospital del Mar and the Hospital del Mar Medical Research Institute, led by the INCLIVA Health Research Institute at Hospital Clínico in Valencia, directed by Dr. Pilar Eroles, Co-coordinator of the Breast Cancer Biology Research Group, has demonstrated, for the first time, that the under-expression of miR-33b is related to a poor prognosis in patients suffering HER2+, one of the most aggressive breast cancers and associated with a low survival rate.
27/11/2020 - Covid-19
The MAPBM (Maturity Assessment Model for Patient Blood Management) project is a useful tool that helps hospitals evaluate and develop their programmes for managing the blood of each patient (better known as PBM or patient blood management). This has been highlighted in an article published in the journal Blood Transfusion, led by doctors from Hospital del Mar and researchers from the Hospital del Mar Medical Research Institute (IMIM). PBM programmes are a set of therapeutic strategies, based on scientific evidence, aimed at improving the patient's condition prior to the surgical procedure, with particular focus on anaemia, minimising bleeding during surgery, and preventing or avoiding blood over-transfusion. They also have a direct impact by reducing the use of hospital blood reserves.
23/11/2020 - Institutional news
The BAPP (Bioanalysis, Proteomics and Pharmacology), a collaborative centre from the Hospital del Mar Medical Research Institute (IMIM) and the UPF, has obtained the TECNIO accreditation for the period 2020-2023. This seal, which the centre had already obtained in previous editions, is awarded by the Government of Catalonia through ACCIÓN. It identifies and raises the profile of centres with high scientific and technical capacities that are considered to be developers of differential technologies and which are leaders when it comes to transferring their knowledge and technologies to industry. The BAPP is a multidisciplinary centre specialising in research and service activities in four sectors: pharmacology, neurosciences, peptide chemistry, and bioanalysis. Its main focus is the development of new drugs for human and veterinary use. It comprises the Integrated Pharmacology and Systems Neuroscience (Farmacologia Integrada i Neurociència de Sistemes; FINS) research group of the IMIM-Hospital del Mar, on the one hand, and the Proteomics and Protein Chemistry research group from the UPF on the other.
18/11/2020 - Institutional news
Jordi Alonso, director of the Epidemiology and Public Health Programme, Montse Fitó, coordinator of the Cardiovascular Risk and Nutrition research group, Joaquim Bellmunt, a researcher in the Cancer Molecular Therapy research group and Margarita Triguero-Mas, researcher in the Healthy cities and environmental justice (UAB-IMIM) appear on the list of the world's most cited scientists published by Clarivate Analytics, a company that provides services in research, patents and other areas related to innovation. This annual list identifies researchers who have displayed significant influence in their chosen research field(s) through the publication of numerous highly cited articles over the past decade. Their names are drawn from publications that are in the top 1% for citations by field and year of publication in the Web of Science citation index.
17/11/2020 - Press release
Nutritional parameters such as body mass index and tests including albumin and total protein levels quantified prior to lung cancer surgery in patients with chronic obstructive pulmonary disease (COPD) predict their 10 year survival, regardless of tumour-related factors and/or chest surgery. This is reflected in the work of researchers from the CIBER of Respiratory Diseases (CIBERES) and doctors and researchers from the Hospital del Mar Pneumology Service and the Hospital del Mar Medical Research Institute research group on muscle wasting and cachexia in chronic respiratory diseases and lung cancer (IMIM-Hospital del Mar), published in the journal of the Spanish Society of Pneumology and Thoracic Surgery (SEPAR) Archivos de Bronconeumología. The researchers studied the nutritional status of lung cancer and COPD patients who required surgery and the relationship of this with post-operative survival. To do this, they analysed the nutritional status of 125 patients from Hospital del Mar, 87 of whom had COPD and lung cancer and 38 of whom had cancer but no COPD, before they underwent chest surgery. The patients were monitored for 10 years in order to study their differential survival rates according to the presence or absence of COPD.
12/11/2020 - Covid-19
Offering comprehensive and multidisciplinary care to frail older patients admitted for COVID-19 makes it possible to reduce the impact hospitalisation and isolation have on their functional capacity. This has been demonstrated in a study by doctors and nurses at Hospital del Mar, which validates the usefulness of this comprehensive care model, ACE (Acute Care for Elders). The work has been published in the magazine Geriatric Nursing. The study followed 51 patients admitted during the first wave of COVID-19 to the Dr. Emili Mira Centre, a facility at the Mar Health Park that specialises in the care of psychiatric diseases and geriatric patients. The functional deterioration that appears in older adults during a hospital stay for acute illness (30-80% of geriatric patients admitted to hospital suffer a reduction in their capacities as a result of a hospital stay), is even more important in the case of COVID-19 because of the restrictions applied to the isolation units. To avoid this situation, a comprehensive care model, ACE, was implemented.
Servei de Comunicació:
Marta Calsina Freixas(ELIMINAR)
Tel:
(+34) 93 316 06 80
Doctor Aiguader, 88
08226 Barcelona
© Institut Hospital del Mar
d'Investigacions MèdiquesLegal Notice and Privacy Policy | Cookie Policy | Site Index | Accessibility | Find Us | Contact